Stop wasting hours on dense SEC filings. Get AI-powered summaries of any SEC Filings in seconds. Understand key insights and risks, fast.
Currently we only process Form 8-K, 6-K, 3, 4, 144, Schedule 13D and Schedule 13G. We will support more forms in the future.
Filter by Form Type:
Industry:Biotechnologyβ
2026-06-16ANAB144DENNIS MULROY plan to sell securities of ANAPTYSBIO, INC. under Form 144MEDIUM
DENNIS MULROY filed Form 144 to notify SEC of plan to sell 1265 units of ANAPTYSBIO, INC. securities around 2026-06-16, with aggregate market value of $75,900.00. The total outstanding units is 29100902.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactions in past 3 months in...
Small CapBiotechnology
2026-06-16ABOS144DERRELL PORTER plan to sell securities of ACUMEN PHARMACEUTICALS, INC. under Form 144MEDIUM
DERRELL PORTER filed Form 144 to notify SEC of plan to sell 12800 units of ACUMEN PHARMACEUTICALS, INC. securities around 2026-06-16, with aggregate market value of $29,767.68. The total outstanding units is 72227580.0. The amount planned to be sold represents 0.02% of total outstanding units; Recent transactions in pa...
Micro CapBiotechnology
2026-06-16ADPT144Harlan Robins plan to sell securities of Adaptive Biotechnologies Corporation under Form 144MEDIUM
Harlan Robins filed Form 144 to notify SEC of plan to sell 6160 units of Adaptive Biotechnologies Corporation securities around 2026-06-16, with aggregate market value of $106,075.20. The total outstanding units is 160044392.0. The amount planned to be sold represents 0.00% of total outstanding units; Recent transactio...
Mid CapBiotechnology
2026-06-16AURA144Gibney Anthony plan to sell securities of Aura Biosciences, Inc. under Form 144MEDIUM
Gibney Anthony filed Form 144 to notify SEC of plan to sell 12824 units of Aura Biosciences, Inc. securities around 2026-06-16, with aggregate market value of $82,330.08. The total outstanding units is 103386558.0. The amount planned to be sold represents 0.01% of total outstanding units; ...
Small CapBiotechnology
2026-06-16BLTE144Dr. Hendrick P. Scholl plan to sell securities of Belite Bio, Inc. under Form 144MEDIUM
Dr. Hendrick P. Scholl filed Form 144 to notify SEC of plan to sell 10000 units of Belite Bio, Inc. securities around 2026-06-16, with aggregate market value of $1,442,400.00. The total outstanding units is 39339960.0. The amount planned to be sold represents 0.03% of total outstanding units; ...
Mid CapBiotechnology